These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23333561)

  • 1. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
    Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
    Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary.
    Godiksen S; Selzer-Plon J; Pedersen ED; Abell K; Rasmussen HB; Szabo R; Bugge TH; Vogel LK
    Biochem J; 2008 Jul; 413(2):251-9. PubMed ID: 18402552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
    Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
    J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
    Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
    J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.
    Denda K; Shimomura T; Kawaguchi T; Miyazawa K; Kitamura N
    J Biol Chem; 2002 Apr; 277(16):14053-9. PubMed ID: 11805118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
    Domoto T; Takino T; Guo L; Sato H
    Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
    Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase.
    Nonboe AW; Krigslund O; Soendergaard C; Skovbjerg S; Friis S; Andersen MN; Ellis V; Kawaguchi M; Kataoka H; Bugge TH; Vogel LK
    Traffic; 2017 Jun; 18(6):378-391. PubMed ID: 28371047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
    Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
    Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the matriptase second CUB domain as the secondary site for interaction with hepatocyte growth factor activator inhibitor type-1.
    Inouye K; Tsuzuki S; Yasumoto M; Kojima K; Mochida S; Fushiki T
    J Biol Chem; 2010 Oct; 285(43):33394-33403. PubMed ID: 20682770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
    Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
    Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease.
    Oberst MD; Chen LY; Kiyomiya K; Williams CA; Lee MS; Johnson MD; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Aug; 289(2):C462-70. PubMed ID: 15800053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
    Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
    J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the regulation of the matriptase-prostasin proteolytic system.
    Holt-Danborg L; Skovbjerg S; Goderum KW; Nonboe AW; Stankevic E; Frost ÁK; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 Nov; 477(22):4349-4365. PubMed ID: 33094801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
    Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
    Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
    Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
    PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane.
    Tseng CC; Jia B; Barndt RB; Dai YH; Chen YH; Du PA; Wang JK; Tang HJ; Lin CY; Johnson MD
    PLoS One; 2020; 15(2):e0228874. PubMed ID: 32049977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.